Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2018 Q1- Text added to 2018 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
abandoned, adult, aim, AimovigTM, alerting, antibody, aooe, array, ARROW, arterial, ballot, begun, bill, blueprint, burden, burdensome, Canada, cap, Carolina, ceiling, certainty, certiorari, choose, CMS, comment, component, conclusion, covered, criteria, debated, density, Donald, ease, EC, effort, EVENITYTM, exerting, formulary, gag, gap, hybrid, incorrect, individually, infarction, infliximab, installment, instrument, introduced, invention, IRP, Kabi, KANJINTITM, large, leverage, maximum, Medicaid, merger, methodology, Middle, mineral, monoclonal, monthly, MSN, myocardial, narrower, narrowing, newer, noninferiority, nonrefundable, North, notify, occasion, overhaul, oversee, ParsabivTM, passed, payer, peripheral, pharmacy, physician, placement, prescribe, prescribed, Prescribing, pressure, proprietary, quickly, rational, REMICADE, rheumatoid, solicited, specialty, statute, systematic, thereon, Torrent, transition, transparency, Trump, uncertain, undertaken, version, widely
Valuein 2018 Q1 filing- Value in 2018 Q2 filing
Original filings
Filing view